Skip to main content
. 2018 May 16;2018:5064684. doi: 10.1155/2018/5064684

Table 3.

Correlation analysis.

MMP-9 TIMP-1 MMP-9/TIMP-1 ratio
Disease severity scores
APACHE II −0.099 0.107 −0.116
SOFA −0.149∗∗ 0.181∗∗ −0.196∗∗
Biomarkers of inflammation
WBC 0.377∗∗ 0.018 0.268∗∗
CRP −0.047 0.019 −0.037
PCT −0.246∗∗ 0.150 −0.214∗∗
Biomarkers of kidney injury
Urea −0.154∗∗ 0.103 −0.167∗∗
Creatinine −0.187∗∗ 0.153∗∗ −0.234∗∗
Serum NGAL −0.089 0.271∗∗ −0.203∗∗
Urine NGAL −0.277∗∗ 0.197∗∗ −0.338∗∗
KIM-1 0.002 0.144∗∗ −0.104
Biomarkers of liver injury
AST −0.145 0.236∗∗ −0.210∗∗
ALT −0.051 0.148 −0.097
Total bilirubin −0.290∗∗ 0.102 −0.266∗∗
Direct bilirubin −0.299∗∗ 0.143 −0.263∗∗
Biomarkers of coagulation
Platelets 0.371∗∗ −0.103 0.329∗∗
INR −0.112 0.153 −0.127
aPTT −0.143 0.102 0.135
Biomarkers of metabolic disorders
Total protein 0.113 −0.109 0.120
Glucose −0.062 0.270∗∗ −0.246∗∗
Lactate −0.211∗∗ 0.263∗∗ −0.275∗∗

Kendall's Tau-b correlation analysis. ∗∗The correlation is significant at the 0.01 level (2-tailed); the correlation is significant at the 0.05 level (2-tailed). MMP-9: matrix metalloproteinase-9; TIMP-1: tissue inhibitor of matrix metalloproteinase-1; APACHE II: Acute Physiology and Chronic Health Evaluation II score; SOFA: Sequential Organ Failure Assessment score; WBC: white blood cell; CRP: C-reactive protein; PCT: procalcitonin; NGAL: neutrophil gelatinase-associated lipocalin; KIM-1: kidney injury molecule-1; AST: aspartate aminotransferase; ALT: alanine aminotransferase; INR: international normalized ratio; aPTT: activated partial thromboplastin time.